# AASLD 2018 Hepatitis B Guidance on Immunosuppressive Therapy

AASLD 2018 乙肝指导中关于免疫抑制或细胞毒性治疗相关 HBV 再激活预防、筛查、预防性抗病毒治疗和监测的建议。

- Original URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC5975958/
- Organization: American Association for the Study of Liver Diseases
- Country or region: United States
- Language: en
- Source type: guideline
- Published: 
- Source updated: 
- Last checked: 2026-06-26
- Credibility note: 专业肝病学会指南

## Related Articles

- [Before chemotherapy, immunosuppression, or biologics: do not miss hepatitis B reactivation risk](https://openhbv.com/articles/before-chemotherapy-immunosuppression-or-biologics-do-not-miss-hepatitis-b-reactivation-risk.md?locale=en) — What HBV reactivation means, which treatments should trigger screening, and what to ask before cancer or immune-suppressing therapy starts.

This page is a source record, not medical advice. Use the original source URL above to verify claims, publication details, updates, and scope. OpenHBV records the last checked date so readers and LLM retrieval systems can judge freshness.